Trial Profile
Randomized,Double-blind,Single-dosing,Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 With Active Comparator
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2013
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2011 New trial record